Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals-Reference-Cited by-同舟云学术

Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals

Published:2023-10-28 Issue:12 Volume:62 Page:1808-1814
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Skribek Marcus¹²^ORCID,Brunnström Hans³⁴^ORCID,Oskarsdottir Gudrun⁵⁶,Portu Grivé Mikel⁷,Aricak Ozan⁸⁹,Planck Maria⁵⁶,Jatta Kenbugul¹⁸^ORCID,Naserhojati Homeyra¹⁸,Haglund de Flon Felix¹⁸,Ekman Simon¹²^ORCID

Affiliation:

1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

2. Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden

3. Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden

4. Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden

5. Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden

6. Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund, Sweden

7. Medical Oncology Department, Catalan Institute of Oncology, Barcelona, Spain

8. Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden

9. Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden

Funder

the Stockholm Cancer Society

Konung Gustaf V:s Jubileumsfond

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2269310

Reference26 articles.

1. Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives

2. MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review

3. MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non–Small Cell Lung Carcinoma with Poor Prognosis

4. MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review

5. Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges